Bo Shan

Bo Shan is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals and imaging technologies. With a total of 5 patents, his work focuses on innovative compounds and methods that have the potential to impact medical treatments.

Latest Patents

Among his latest patents, Bo Shan has developed PRMT5 inhibiting compounds and their uses. This application provides novel PRMT5 and/or MTA-cooperative PRMT5 inhibiting compounds, or pharmaceutically acceptable salts thereof. It also includes pharmaceutical compositions comprising these compounds as active ingredients, aimed at treating diseases or disorders, including cancers. Another notable invention is related to imaging neuroinflammation. This invention concerns in vivo imaging, particularly of the peripheral benzodiazepine receptor (PBR). It introduces a tetracyclic indole in vivo imaging agent that binds with high affinity to PBR, demonstrating good uptake into the brain after administration. The invention also includes a precursor compound useful in synthesizing the imaging agent, along with a method and a kit for its synthesis.

Career Highlights

Bo Shan has worked with notable companies such as GE Healthcare Limited and Antengene Discovery Limited. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical and imaging sectors.

Collaborations

Throughout his career, Bo Shan has collaborated with esteemed colleagues, including Dennis O'Shea and William John Trigg. These partnerships have contributed to the advancement of his research and inventions.

Conclusion

Bo Shan's contributions to the fields of pharmaceuticals and imaging technologies highlight his innovative spirit and dedication to improving medical treatments. His patents reflect a commitment to advancing science and technology for the benefit of society.

This text is generated by artificial intelligence and may not be accurate.